A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors
for Cancer
5 locations incl. Beverly Hills
Sponsor: Jaime Leandro Foundation for Therapeutic Cancer Vaccines
Sex: All·Age: 12+
Code: NCT05741242·Phase 1, Phase 2·Enrolling By Invitation